Mangrove Partners Teva Pharmaceutical Industries LTD Transaction History
Mangrove Partners
- $642 Million
- Q4 2024
A detailed history of Mangrove Partners transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Mangrove Partners holds 1,932,427 shares of TEVA stock, worth $33.2 Million. This represents 6.64% of its overall portfolio holdings.
Number of Shares
1,932,427
Previous 2,147,141
10.0%
Holding current value
$33.2 Million
Previous $38.7 Million
10.08%
% of portfolio
6.64%
Previous 5.03%
Shares
3 transactions
Others Institutions Holding TEVA
# of Institutions
673Shares Held
578MCall Options Held
25.5MPut Options Held
14.7M-
Black Rock Inc. New York, NY43MShares$738 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$669 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.7MShares$629 Million48.01% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$487 Million3.94% of portfolio
-
Exor Capital LLP London, X027.2MShares$467 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19.1B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...